Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ATM | Q13315 | 1/20 | 0.42 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.42 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL24090557 | 0.90 | ATM (0.38) | ATML3MBTL1 | |
| SCHEMBL24090568 | 0.88 | ATM (0.41) | ATML3MBTL1 | |
| SCHEMBL24090571 | 0.84 | PIK3CD (0.48) | ATML3MBTL1 | |
| SCHEMBL24090572 | 0.84 | GLB1 (0.48) | ATML3MBTL1 | |
| SCHEMBL24090566 | 0.84 | ATM (0.35) | ATML3MBTL1 | |
| SCHEMBL24090573 | 0.84 | ATM (0.35) | ATML3MBTL1 | |
| SCHEMBL24090570 | 0.81 | ATM (0.33) | ATML3MBTL1 | |
| SCHEMBL24090564 | 0.78 | GBA1 (0.41) | — | |
| SCHEMBL18820456 | 0.77 | — | — | |
| SCHEMBL18459129 | 0.77 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3868763-B1 | COMPOUND AND METHOD FOR PRODUCING SAME | UNIV OSAKA (JP) | 2024-07-03 | — | — | EP | disclosed |
| US-20220144789-A1 | HYDROGENATION CATALYST USED IN AMIDE COMPOUND HYDROGENATION AND METHOD FOR PRODUCING AMINE COMPOUND USING SAME | OSAKA UNIVERSITY (JP) | 2022-05-12 | — | — | US | disclosed |
| US-20210380594-A1 | COMPOUND, AND METHOD FOR PRODUCING THE SAME | N.E. CHEMCAT CORPORATION (JP) | 2021-12-09 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210380594-A1 | COMPOUND, AND METHOD FOR PRODUCING THE SAME | POR, CYP19A1, CYP1A1 | ATM 1738/4885L3MBTL1 4418/4885SMN1; SMN2 3956/4885 |
| US-20220144789-A1 | HYDROGENATION CATALYST USED IN AMIDE COMPOUND HYDROGENATION AND METHOD FOR PRODUCING AMINE COMPOUND USING SAME | HRH3, HRH4, H1-4 | ATM 297/4885L3MBTL1 3653/4885SMN1; SMN2 3704/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.